|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
25 May 2015 |
|
Main ID: |
NCT02226419 |
|
Date of registration:
|
05/08/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter Deficiency
CTD |
|
Scientific title:
|
Fat and Carbohydrate Metabolism During Exercise, With and Without L-carnitine Supplementation in Patients With Carnitine Transporter Deficiency |
|
Date of first enrolment:
|
August 2013 |
|
Target sample size:
|
14 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02226419 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Karen L Madsen, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Neuromuscular Research Unit, Rigshospitalet |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Verified diagnosis of CTD
Exclusion Criteria:
- Other conditions or diseases that may compromise the outcome of the study
- Pregnancy or lactation
- Inability to cooperate carrying out the experiments
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Carnitine Transporter, Plasma-membrane, Deficiency of
|
|
Intervention(s)
|
|
Dietary Supplement: Break in L-carnitine treatment
|
|
Primary Outcome(s)
|
|
The whole body palmitate and carbohydrate oxidation rate in CTD patients during exercise
[Time Frame: With and without L-carnitine treatment]
|
|
Secondary Outcome(s)
|
|
The maximal oxidative capacity (VO2max) as an indicator of exercise tolerance and performance in CTD patients
[Time Frame: During a 15 min incremental intensity exercise test and during a 1h moderate intensity cycling test]
|
|
Secondary ID(s)
|
|
H-1-2012-130
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|